Last reviewed: 10 September 2026. Section 194R has been in force since 1 July 2022, requiring TDS at 10% on the value of any benefit or perquisite arising from business or profession that a person provides to a resident, once the aggregate value crosses ₹20,000 in a financial year. Four years in, the section itself is well understood, but assessments and TDS surveys continue to throw up disputes on the same recurring question: how do you value a non-cash benefit, and does a particular scheme item count as a “benefit” at all, or is it a discount, a rebate, or a genuine expense reimbursement that falls outside the section altogether? With the section carried forward as Section 393 under the Income-tax Act 2025 from FY 2026-27, businesses running dealer or doctor incentive schemes need a durable classification framework, not a scheme-by-scheme guess.
What Section 194R actually requires
Section 194R casts an obligation on any person carrying on a business or profession who provides a benefit or perquisite, whether convertible into money or not, to a resident, arising from that resident's business or the exercise of their profession, to deduct tax at 10% before the benefit is given, once the aggregate value of such benefits to that resident exceeds ₹20,000 in a financial year. Where the benefit is entirely in kind, with no cash component from which tax can be withheld, the provider must either ensure the recipient has paid the applicable tax on the benefit before releasing it, or gross up and bear the tax itself. From FY 2026-27, the same obligation is carried forward as Section 393 of the Income-tax Act 2025, with the substance unchanged. The provision was introduced specifically to bring within the tax net a category of business perquisites — free products, sponsored trips, gifts, sales-target incentives — that were often not being offered for taxation by recipients even though they represented real economic value flowing from a business relationship.
The three recurring dispute areas
The first and most litigated area is valuation. For a cash benefit, valuation is trivial; for a non-cash benefit — a free product sample, a sponsored international trip for a doctor or a top-performing dealer, a gift hamper, or a product demonstration unit that the recipient keeps — the section itself gives limited guidance, and CBDT Circulars 12/2022 and 18/2022, while helpful for illustrative situations, leave many real transactions in a grey area. Valuation questions include whether a sponsored trip should be valued at the actual cost incurred by the sponsor or at what it would have cost the recipient to buy the same trip commercially, and how to value a product that has no established retail price because it is not separately sold. The second area is the discount-versus-benefit line. CBDT has clarified that discounts and rebates given in the ordinary course of business, and reflected in the invoice or effectively reducing the sale price, are not “benefits” under Section 194R at all — a straightforward price reduction is not income in the hands of the buyer, so there is nothing to tax. Incentives given after the sale is already complete — a bonus trip, a gadget, a year-end hamper tied to achieving a sales target — are treated differently, since they are not a reduction in the price of what was bought but a separate item of value conferred because of the business relationship, and generally do attract 194R. The third area is reimbursement versus benefit: where a dealer or professional incurs a genuine business expense on the payer's behalf (for example, travel for a joint sales visit, billed in the payer's name) and is reimbursed, that reimbursement is excluded from 194R because it is not a benefit at all — it is the payer meeting its own cost, routed through the recipient. The dispute arises where documentation is thin: if the underlying bills are not in the payer's name, or there is no clear expense-and-reimbursement trail, the department can and does recharacterise the payment as a disguised benefit.
Table: how to classify a common scheme item
| Scheme item | Typical treatment | Why |
|---|---|---|
| Volume/quantity discount shown on the invoice | Not a benefit — no 194R | Reduces the sale price in the ordinary course; CBDT has expressly excluded this |
| Cash-back credited against a future purchase | Generally not a benefit if it reduces the effective price of a purchase | Functions as a price reduction rather than a separate item of value |
| Sponsored foreign trip for top dealers/doctors | Benefit — 194R applies | Conferred after the underlying business relationship, not a price reduction |
| Free product sample for evaluation | Benefit if value exceeds the threshold in aggregate | Has independent value to the recipient, not tied to a specific concluded sale |
| Reimbursement of travel expense for a joint client visit (bills in payer's name) | Not a benefit — no 194R | Payer is meeting its own cost; no value is conferred on the recipient |
| Product demo unit retained permanently by the dealer | Benefit — 194R applies on the unit's value | Recipient retains something of lasting value beyond the demonstration purpose |
Worked example: a pharma company's doctor incentive scheme
A pharmaceutical company runs a scheme under which doctors who prescribe a minimum volume of its product in a quarter are sponsored for a domestic conference trip (flights, hotel, and conference fee), with the company's actual cost per doctor averaging ₹48,000. Across a financial year, twelve doctors qualify for one such trip each, and no other benefits are given to them. Since each doctor's aggregate benefit for the year (₹48,000) exceeds the ₹20,000 threshold, Section 194R applies to each of them individually — the company must deduct TDS at 10% of ₹48,000, i.e. ₹4,800 per doctor, before or at the time of providing the benefit. Because the benefit is entirely in kind (travel and accommodation, no cash paid to the doctor), the company cannot simply withhold ₹4,800 from a payment that does not exist — it must either collect ₹4,800 from each doctor before booking the trip (rare in practice) or, more commonly, gross up the benefit and bear the tax itself, in which case the taxable value effectively becomes higher than ₹48,000 to account for the tax borne. If the company instead values the trip at a lower “notional” figure not supported by actual cost or a defensible fair-value basis, and this is queried in a TDS survey, the shortfall in tax deducted becomes the company's own liability under Section 201, along with interest, quite apart from any penalty — which is exactly the valuation exposure that makes documenting the actual cost basis for every non-cash benefit important from the outset.
Common mistakes and red flags
- Treating every dealer/doctor scheme item as automatically outside 194R because it is called a “discount” in internal scheme documents, without checking whether it is genuinely reflected in the invoice/sale price.
- Not tracking the ₹20,000 aggregate threshold per recipient across the full financial year and across multiple scheme types — a series of small benefits to the same person can cumulatively cross the threshold even if no single item does.
- Valuing non-cash benefits at an arbitrary or unsupported figure rather than actual cost incurred or a documented fair-value basis.
- Reimbursing recipient expenses without requiring bills in the payer's own name, which weakens the “genuine reimbursement, not a benefit” position if challenged.
- Failing to gross up correctly (or at all) where a wholly-in-kind benefit is provided and the recipient has not separately paid the tax, leaving the payer short-deducted.
- Applying an ad hoc, scheme-by-scheme judgment call each time instead of a documented, consistent classification policy across the organisation's incentive programmes.
What should you do now
Every business running dealer, distributor, doctor or channel-partner incentive schemes should map each scheme item into one of three buckets and document the basis for each: (i) a price reduction reflected in invoicing, outside 194R; (ii) a genuine expense reimbursement with bills in the payer's name, outside 194R; or (iii) a benefit or perquisite, valued at actual cost or a documented fair-value basis, with 194R applied — TDS deducted where possible, or the benefit grossed up and tax borne where it is wholly in kind. This classification should be built into the scheme design itself, not decided retrospectively when a TDS survey or assessment raises the question, since ad hoc, inconsistent treatment across similar scheme items is precisely the pattern that draws scrutiny. Finance teams should also maintain a running per-recipient tally against the ₹20,000 threshold, since the obligation is cumulative across the year, not per-transaction.
Frequently asked questions
What is the TDS rate and threshold under Section 194R?
10% TDS applies on the value of a business benefit or perquisite provided to a resident, once the aggregate value of such benefits to that recipient exceeds ₹20,000 in a financial year. The threshold is cumulative across the year and across different scheme items to the same recipient, not per transaction.
Are ordinary trade discounts covered by Section 194R?
No. CBDT has clarified that discounts and rebates given in the ordinary course of business, and reflected in the invoice or effectively reducing the sale price, are not “benefits” under Section 194R. Incentives given after the sale is complete, such as trip vouchers or gadgets tied to a sales target, are generally treated differently and do attract 194R.
How should a non-cash benefit like a sponsored trip be valued for TDS purposes?
In the absence of complete statutory guidance, the safer and most defensible approach is to value the benefit at the actual cost incurred by the provider, supported by invoices and documentation, since CBDT Circulars 12/2022 and 18/2022 give only illustrative guidance and many real transactions still fall in a genuinely grey area.
What happens if the benefit is entirely in kind with no cash component?
The provider must either ensure the recipient has paid tax on the value of the benefit before it is released, or gross up the benefit and bear the tax itself, since there is no cash payment from which TDS can otherwise be withheld.
Is reimbursement of a dealer's genuine business expense covered by Section 194R?
Generally no, provided it is a genuine reimbursement of expenditure incurred by the recipient on the payer's behalf, ideally with bills in the payer's own name. Where documentation is thin, the department may recharacterise the payment as a disguised benefit and bring it within 194R.
Does Section 194R still apply under the new Income-tax Act 2025?
Yes. The obligation is carried forward, with the same substance, as Section 393 of the Income-tax Act 2025, applicable from FY 2026-27 onward.
TDS Return FilingIncome Tax FilingTalk to us
This article is general information for educational purposes, not an opinion on any specific case or a substitute for professional advice; the legal position summarised here can change, so please verify current status and consult a qualified professional before acting on your own facts.